Do you want to read an article? Please log in or register.
Asthma-Related Health Outcomes Associated with Short-Acting β2-Agonist Inhaler Use: An Observational UK Study as Part of the SABINA Global Program
Asthma
RECOMMENDED
Related content
RECOMMENDED
Asthma
Asthma-Related Health Outcomes Associated with Short-Acting β2-Agonist Inhaler Use: An Observational UK Study as Part of the SABINA Global Program
★ 2
Recommended by
Dr Martin Frey, Faculty Member
Adv Ther
Bloom CI, Cabrera C, Arnetorp S, Coulton K, Nan C, van der Valk RJP, Quint JK
doi: 10.1007/s12325-020-01444-5
RECOMMENDED
Asthma
SABINA: global programme to evaluate prescriptions and clinical outcomes related to short-acting β2-agonist use in asthma
Eur Respir J.
Cabrera CS, Nan C, Lindarck N, Beekman MJHI, Arnetorp S, van der Valk RJP
doi: 10.1183/13993003.01858-2019.
RECOMMENDED
Asthma
Overuse of short-acting β2-agonists in asthma is associated with increased risk of exacerbation and mortality: A nationwide cohort study of the global SABINA programme
★ 2
Recommended by
Dr Martin Frey, Faculty Member
★ 3
Recommended by
Dr Marcus Hesse, Faculty Member
Eur Respir J.
Nwaru BI, Ekström M, Hasvold P, Wiklund F, Telg G, Janson C
doi: 10.1183/13993003.01872-2019.
RECOMMENDED
AsthmaCOPD
Risk of COVID-19-related death among patients with chronic obstructive pulmonary disease or asthma prescribed inhaled corticosteroids: an observational cohort study using the OpenSAFELY platform
★ 3
Recommended by
Dr Martin Frey, Faculty Member
★ 2
Recommended by
Dr Marcus Hesse, Faculty Member
Lancet Respir Med.
Schultze A, Walker AJ, MacKenna B, Morton CE, Bhaskaran K, Brown JP, Rentsch CT, Williamson E, Drysdale H, Croker R, Bacon S, Hulme W, Bates C, Curtis HJ, Mehrkar A, Evans D, Inglesby P, Cockburn J, McDonald HI, Tomlinson L, Mathur R, Wing K, Wong AYS, Forbes H, Parry J, Hester F, Harper S, Evans SJW, Quint J, Smeeth L, Douglas IJ, Goldacre B, OpenSAFELY Collaborative.
doi: 10.1016/S2213-2600(20)30415-X.
COMMENTED
Asthma
Tiotropium add-on to inhaled corticosteroids versus addition of long-acting β2-agonists for adults with asthma
Respir Med.
Buhl R, FitzGerald JM, Busse WW
doi: 10.1016/j.rmed.2018.08.014.
RECOMMENDED
Asthma
Characteristics of Reliever Inhaler Users and Asthma Control: A Cross-Sectional Multicenter Study in Portuguese Community Pharmacies
★ 1
Recommended by
Dr Martin Frey, Faculty Member
★ 1
Recommended by
Dr Marcus Hesse, Faculty Member
J Asthma Allergy
Romão M, Godinho AR, Teixeira PM, Mendes Z, Bernardo F, Teixeira Rodrigues A, Correia de Sousa J
doi: 10.2147/JAA.S315678
Diagnosis and management of asthma - Statement on the 2015 GINA Guidelines
Horak F, Doberer D, Eber E, Horak E, Pohl W, Riedler J, Szépfalusi Z, Wantke F, Zacharasiewicz A, Studnicka M
COPD
Assessing the healthcare resource use associated with inappropriate prescribing of inhaled corticosteroids for people with chronic obstructive pulmonary disease (COPD) in GOLD groups A or B: an observational study using the Clinical Practice Research Datalink (CPRD)
Respir Res.
Chalmers JD, Poole C, Webster S, Tebboth A, Dickinson S, Gayle A
doi: 10.1186/s12931-018-0767-2.
RECOMMENDED
Asthma
Risk of adverse outcomes in patients with underlying respiratory conditions admitted to hospital with COVID-19: a national, multicentre prospective cohort study using the ISARIC WHO Clinical Characterisation Protocol UK
★ 3
Recommended by
Dr Martin Frey, Faculty Member
Lancet Respir Med
Bloom CI, Drake TM, Docherty AB, Lipworth BJ, Johnston SL, Nguyen-Van-Tam JS, Carson G, Dunning J, Harrison EM, Baillie JK, Semple MG, Cullinan P, Openshaw PJM, ISARIC investigators.
doi: 10.1016/S2213-2600(21)00013-8